Ekso Bionics adds Howard Palefsky to board
Mr. Palefsky is a veteran in the healthcare industry who has extensive experience as an entrepreneur, CEO, board chair, director and investor in the life sciences, including medical devices.
Mr. Palefsky is currently an active advisor or board member to multiple companies in the healthcare arena, including Olatec Therapeutics, Adigica Health, Life Sciences Alternative Funding and Victoria Capital Management.
Previously, he was a managing director at Montreux Equity Partners as well as chairman and CEO of a Montreux portfolio company, NeurogesX.
From 1978 to 1997, Mr. Palefsky was the chairman, president and CEO of Collagen Corporation, a pioneer in the aesthetic medicine field.
He led Collagen from a pre-revenue, venture funded start up through numerous financings, product approvals, international launches and profitability, all of which culminated in Collagen's initial public offering.
Mr. Palefsky then managed the creation of Collagen's spin-off companies and each of their ultimate acquisitions. ■
LATEST MOVES FROM California
- Penumbra appoints Bridget O'Rourke to board
- Adverum Biotechnologies adds Richard N. Spivey to board
- Lombard Medical appoints Kurt Lemvigh as CEO
- CareDx appoints Michael Bell as CFO
- Visa appoints John F. Lundgren as director
More inside POST